Status:
RECRUITING
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Lead Sponsor:
Technische Universität Dresden
Collaborating Sponsors:
German Sarcoma Foundation (DSS)
German Cancer Research Center
Conditions:
Sarcoma
Survivorship
Eligibility:
All Genders
18+ years
Brief Summary
The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or...
Detailed Description
Sarcomas are rare cancers that can arise almost anywhere in the body and account for only about one percent of all cancer diagnoses. Both the disease and its treatments often result in late effects, y...
Eligibility Criteria
Inclusion
- Diagnosis of sarcoma according to the International Classification of Diseases for Oncology (ICD-O) and World Health Organization (WHO) classification, including soft tissue sarcoma, bone sarcoma, and GIST
- At least 5 years since initial sarcoma diagnosis
- With or without active disease
- Age ≥18 years at the time of study participation
Exclusion
- Diagnosis of Desmoid tumors
- Inability to complete a structured questionnaire (e.g., due to insufficient German language skills, cognitive impairment, dementia)
Key Trial Info
Start Date :
November 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT07148193
Start Date
November 28 2025
End Date
September 1 2027
Last Update
December 8 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Technical University Dresden
Dresden, Saxony, Germany
2
University Hospital Essen
Essen, Germany
3
NCT Heidelberg
Heidelberg, Germany
4
Sarcoma Center Mannheim
Mannheim, Germany